Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: A double-blind randomized cross-over controlled clinical trial

Clinical Nutrition

Volumn 35, Issue 4, 2016, Pages 819-825

  Asemi, Zatollah ^a   Alizadeh, Sabihe Alsadat ^b   Ahmad, Khorshidi ^a   Goli, Mohammad ^c   Esmaillzadeh, Ahmad ^d,e  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Research and Development of Sekkeh Gaz Company ^*  (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Inflammation; Metabolic profiles; Oxidative stress; Synbiotic; Type 2 diabetes

Indexed keywords

BETA CAROTENE; CHOLESTEROL; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INULIN; MALONALDEHYDE; NITRIC OXIDE; PLACEBO; PROBIOTIC AGENT; SYNBIOTIC AGENT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; FOOD COMPOSITION; FOOD INTAKE; FOOD PACKAGING; HUMAN; INSULIN BLOOD LEVEL; LACTOBACILLUS; LACTOBACILLUS SPOROGENES; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; BACILLUS COAGULANS; BLOOD; DRUG EFFECTS; FORTIFIED FOOD; GLUCOSE BLOOD LEVEL; INFLAMMATION; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS;

ADULT; AGED; BACILLUS COAGULANS; BETA CAROTENE; BIOMARKERS; BLOOD GLUCOSE; CHOLESTEROL; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; FOOD, FORTIFIED; GLUTATHIONE; HUMANS; INFLAMMATION; INSULIN; INULIN; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; SYNBIOTICS; TRIGLYCERIDES;

EID: 84937509162     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.07.009     Document Type: Article

References (29)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37(Suppl 1):S81-S90.
2. DeFronzo R.A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010, 53:1270-1287.
3. Guariguata L. Contribute data to the 6th edition of the IDF diabetes Atlas. Diabetes Res Clin Pract 2013, 100:280-281.
4. Vaidya V., Gangan N., Sheehan J. Impact of cardiovascular complications among patients with type 2 diabetes mellitus: a systematic review. Expert Rev Pharmacoecon Outcomes Res 2015, 1-11.
5. Banerjee M., Vats P. Reactive metabolites and antioxidant gene polymorphisms in type 2 diabetes mellitus. Indian J Hum Genet 2014, 20:10-19.
6. Johnson E.L. Glycemic variability in type 2 diabetes mellitus: oxidative stress and macrovascular complications. Adv Exp Med Biol 2012, 771:139-154.
7. Astrup A.S., Tarnow L., Rossing P., Pietraszek L., Riis Hansen P., Parving H.H. Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study. Kidney Int 2005, 68:1250-1257.
8. Fioretto P., Solini A. Antihypertensive treatment and multifactorial approach for renal protection in diabetes. J Am Soc Nephrol 2005, 16(Suppl 1):S18-S21.
9. Asemi Z., Khorrami-Rad A., Alizadeh S.A., Shakeri H., Esmaillzadeh A. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr 2014, 33:198-203.
10. Shakeri H., Hadaegh H., Abedi F., Tajabadi-Ebrahimi M., Mazroii N., Ghandi Y., et al. Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes. Lipids 2014, 49:695-701.
11. Ciccone M.M., Cortese F., Gesualdo M., Carbonara S., Zito A., Ricci G., et al. Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular care. Mediat Inflamm 2013, 2013:782137. [Epub 31.12.2013]. 10.1155/2013/782137.
12. Vincent H.K., Bourguignon C.M., Weltman A.L., Vincent K.R., Barrett E., Innes K.E., et al. Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults. Metabolism 2009, 58:254-262.
13. Yu F., Hao S., Zhao Y., Yang H., Fan X.L., Yang J. In utero and lactational beta-carotene supplementation attenuates D-galactose-induced hearing loss in newborn rats. Food Chem Toxicol 2011, 49:1697-1704.
14. Canas J.A., Damaso L., Altomare A., Killen K., Hossain J., Balagopal P.B. Insulin resistance and adiposity in relation to serum beta-carotene levels. J Pediatr 2012, 161. 58-64 e1-2.
15. Williams C.M. Effects of inulin on lipid parameters in humans. J Nutr 1999, 129:1471S-1473S.
16. Yadav H., Lee J.H., Lloyd J., Walter P., Rane S.G. Beneficial metabolic effects of a probiotic via butyrate induced GLP-1 secretion. J Biol Chem 2013, 288(35):25088-25097.
17. Lutgendorff F., Trulsson L.M., van Minnen L.P., Rijkers G.T., Timmerman H.M., Franzen L.E., et al. Probiotics enhance pancreatic glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2008, 295:G1111-G1121.
18. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35(Suppl 1):S64-S71.
19. Malaguarnera M., Vacante M., Antic T., Giordano M., Chisari G., Acquaviva R., et al. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci 2012, 57:545-553.
20. Taghizadeh M., Hashemi T., Shakeri H., Abedi F., Sabihi S.S., Alizadeh S.A., et al. Synbiotic food consumption reduces levels of triacylglycerols and VLDL, but not cholesterol, LDL, or HDL in plasma from pregnant women. Lipids 2014, 49(2):155-161.
21. Trautwein E.A., Rieckhoff D., Erbersdobler H.F. Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters. J Nutr 1998, 128:1937-1943.
22. Cheng C.P., Tsai S.W., Chiu C.P., Pan T.M., Tsai T.Y. The effect of probiotic-fermented soy milk on enhancing the NO-mediated vascular relaxation factors. J Sci Food Agric 2013, 93:1219-1225.
23. Bruzzese E., Raia V., Gaudiello G., Polito G., Buccigrossi V., Formicola V., et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004, 20:813-819.
24. Hagobian T.A., Jacobs K.A., Subudhi A.W., Fattor J.A., Rock P.B., Muza S.R., et al. Cytokine responses at high altitude: effects of exercise and antioxidants at 4300 m. Med Sci Sports Exerc 2006, 38:276-285.
25. Giamarellos-Bourboulis E.J., Bengmark S., Kanellakopoulou K., Kotzampassi K. Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. J Trauma 2009, 67:815-821.
26. Baeten J.M., McClelland R.S., Wener M.H., Bankson D.D., Lavreys L., Mandaliya K., et al. Relationship between markers of HIV-1 disease progression and serum beta-carotene concentrations in Kenyan women. Int J STD AIDS 2007, 18:202-206.
27. Komers R., Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Ren Physiol 2003, 284:F1121-F1137.
28. Peran L., Camuesco D., Comalada M., Nieto A., Concha A., Diaz-Ropero M.P., et al. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J Gastroenterol 2005, 11:5185-5192.
29. Matthews G.M., Howarth G.S., Butler R.N. Short-chain fatty acid modulation of apoptosis in the Kato III human gastric carcinoma cell line. Cancer Biol Ther 2007, 6:1051-1057.